Research ArticleDISEASES AND DISORDERS

A gene therapy for inherited blindness using dCas9-VPR–mediated transcriptional activation

See allHide authors and affiliations

Science Advances  19 Aug 2020:
Vol. 6, no. 34, eaba5614
DOI: 10.1126/sciadv.aba5614

Article Information

vol. 6 no. 34

PubMed: 
Online ISSN: 
History: 
  • Received for publication December 13, 2019
  • Accepted for publication July 8, 2020
  • .

Author Information

  1. Sybille Böhm1,2,*,
  2. Victoria Splith1,2,*,
  3. Lisa Maria Riedmayr1,2,
  4. René Dominik Rötzer1,2,
  5. Gilles Gasparoni3,
  6. Karl J. V. Nordström3,
  7. Johanna Elisabeth Wagner1,2,
  8. Klara Sonnie Hinrichsmeyer1,2,
  9. Jörn Walter3,
  10. Christian Wahl-Schott4,
  11. Stefanie Fenske1,2,
  12. Martin Biel1,2,
  13. Stylianos Michalakis1,2,5 and
  14. Elvir Becirovic1,2,
  1. 1Center for Integrated Protein Science Munich CIPSM, Munich, Germany.
  2. 2Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
  3. 3Department of Genetics, Saarland University, Saarbrücken, Germany.
  4. 4Institute for Neurophysiology, Hannover Medical School (MHH), Hanover, Germany.
  5. 5Department of Ophthalmology, Ludwig-Maximilians-Universität München, Munich, Germany.
  1. Corresponding author. Email: elvir.becirovic{at}cup.uni-muenchen.de
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: August 2020 to August 2021

AbstractFullPdf
Aug 20202553145594
Sep 2020971538434
Oct 202053676189
Nov 202046589194
Dec 202010649114
Jan 202127619173
Feb 202121492136
Mar 202129475139
Apr 202126387105
May 20213939999
Jun 202128278109
Jul 20211221080
Aug 20210710

Stay Connected to Science Advances

Navigate This Article